Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The actin-like 8 pseudogene (ENSG00000278687) is a non-functional genomic element related to the protein-coding gene ACTL8. Like other pseudogenes, it does not encode a functional protein and is generally not considered a direct therapeutic target. Pseudogenes can have regulatory roles or serve as biomarkers in cancer genomics, but there is currently no evidence that actin-like 8 pseudogene is a validated drug target or involved in canonical biological processes. ACTL8P/ENSG00000278687 is a pseudogene, which means it is a non-functional relic of a gene. It should not be confused with ACTL8 (actin-like protein 8), which is a protein-coding gene with demonstrated roles in cancer cell proliferation and may be a potential target for therapy in some contexts. Pseudogenes, including actin-like 8 pseudogene, may have regulatory functions in gene expression and could serve as biomarkers in some cancer studies, but their roles are distinct from classical therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin-like 8 pseudogene.